Skip to content

Aulos Bioscience vs Pyxis Oncology

Aulos Bioscience logo

Aulos Bioscience

We’re revolutionizing #cancercare through #IL2 therapeutics designed to direct the #immunesystem to destroy cancers

15 employees · est. 2020 · Larkspur, United States

VS
Pyxis Oncology logo

Pyxis Oncology

Charting a course to therapeutics for difficult-to-treat cancer

68 employees · est. 2019 · Boston, United States

Pyxis Oncology is the older company (2020 vs 2019); Pyxis Oncology is the larger of the two.

Side-by-Side Comparison

Aulos Bioscience Pyxis Oncology
Founded
2020 2019 older
Headquarters
Larkspur, United States Boston, United States
Employees
15 68 larger
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care, Pharmaceutical
Funding Stage
Series A Not tracked yet
Total Funding
$60.00M $392.00M
Funding Rounds
2 4
Services
Not tracked yet development of antibody-drug conjugates, immunotherapy research, clinical program management, oncology-focused drug development
Target Customers
Not tracked yet patients with difficult-to-treat cancers, healthcare professionals, oncologists, medical researchers
Taxonomy
Immuno-oncologyIL-2 TherapeuticsCancer CareImmune SystemClinical CandidateTumor Killing +7 Antibody-Drug ConjugatesImmunotherapyCancer TreatmentBiologicsTumor TargetingImmune Suppression Overcoming +8
Website
aulosbio.com pyxisoncology.com
Aulos Bioscience logo

About Aulos Bioscience

Aulos Bioscience is an immuno-oncology company that aims to revolutionize cancer patient care through its computationally designed IL-2 therapeutics. The company's flagship clinical candidate, AU-007, has been engineered to leverage a patient's own IL-2 to induce tumor killing while minimizing assoc...

Pyxis Oncology logo

About Pyxis Oncology

Pyxis Oncology, founded in 2019, is a biotech innovator based in the United States, focused on transformative cancer therapies. With a mission expressed through their slogan, "Charting a course to therapeutics for difficult-to-treat cancer," Pyxis aims to change the landscape of cancer treatment. T...

Also comparing in this category

Comparing more than these two?

Get Aulos Bioscience, Pyxis Oncology and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Aulos Bioscience compare?

A PDF of Aulos Bioscience and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Aulos Bioscience was founded in 2020, based in Larkspur, United States, with 15 employees. Aulos Bioscience is an immuno-oncology company that aims to revolutionize cancer patient care through its computationally designed IL-2 therapeutics. The company's flagship clinical candidate, AU-007,. Pyxis Oncology was founded in 2019, based in Boston, United States, with 68 employees. Pyxis Oncology, founded in 2019, is a biotech innovator based in the United States, focused on transformative cancer therapies. With a mission expressed through their slogan, "Charting a course to the.
Aulos Bioscience has raised $60.00M and Pyxis Oncology $392.00M. Latest stage: Aulos Bioscience Series A.
Both work in Biotechnology and Health Care.

Compare Aulos Bioscience with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Aulos Bioscience on 9 Jun 2026, and Pyxis Oncology on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout